91亚色传媒

News

The top scientific breakthrough for 2020

David Pride
By David Pride
Dec. 27, 2020

SARS-CoV-2, the virus that causes the respiratory illness COVID-19, of those worldwide who are known to have contracted it. But the situation could be a lot worse without modern medicine and science.

The last such global scourge was the influenza pandemic of 1918, which is estimated to have at a time when there was no internet or easy access to long-distance telephones to disseminate information. Science was limited, which made it difficult to identify the cause and initiate vaccine development. The world is 100% more prepared for the current pandemic than it was 100 years ago. However, it has still affected our lives profoundly.

who specializes in the study of viruses and runs a microbiology laboratory that tests for SARS-CoV-2 infections. I've seen firsthand patients with severe COVID-19 illness and have dedicated myself to developing diagnostics for this disease. It's a remarkable testament to science that a novel disease-causing virus has been discovered, the genetic material completely decoded, new therapies created to fight it and multiple safe and effective vaccines developed all within the span of a year – an accomplishment that the journal .

Most vaccines . Until now the , which took four years. Now, in the midst of the SARS-CoV-2 pandemic, , with a second close behind. Other vaccines have already been rolled out in countries across the globe.

Science fast-tracked

This pandemic put science front and center. One of the most significant scientific advances in the past 15 years has been the ability to . The process of sequencing the genome of a virus is called , and it has revolutionized science by allowing researchers to rapidly decode the genome of a virus or bacterium, quickly and cost-effectively. This strategy was used to before epidemiologists even recognized that it had already spread around the world. Obtaining the sequence allowed for the and to figure out who was infected and how the virus might spread.

was responsible for an but was not particularly contagious and was limited mostly to Southeast Asia.

SARS-CoV-2 has evolved two separate qualities that allow it to spread more easily. First, it has an enormous potential for , in which the virus infects carriers who don't experience symptoms and may never know they are infected and transmitting the virus to others.

Second, it can spread via aerosolized particles. Most of these , which are visible and fall out of the air within three to six feet. But SARS-CoV-2 can also that remain in the air for several hours.

While in 1918 people went on , this time around, science provided us with concrete answers. There have been demonstrating the efficacy of masking. These types of studies inform the public that decrease circulating virus and thus reduce hospitalizations and death. While they don't get much fanfare, these studies are among the most important discoveries in response to this pandemic.

Masks-890x593.jpg
Masks work for cutting transmission of the coronavirus.

Science aids diagnostics

, which is short for polymerase chain reaction. This method uses specialized proteins and virus-matching DNA sequences called primers to create more copies of the virus. These additional copies allow PCR machines to detect the presence of the virus; doctors can then tell you if you are infected. Because of the availability of the virus's genome sequence, any researcher can design primers that match the virus to develop a diagnostic test.

to detect the virus and to researchers and physicians around the globe.

This was a remarkable achievement that allowed countries across the world to rapidly develop diagnostic tests using this template. This distribution changed the course of the pandemic in many countries.

Treatments have lowered mortality rates

Treatments for infectious diseases often evolve over time. There is , but over recent years treatments have evolved from those that make you very ill to those that are highly efficacious with few side effects.

We are now seeing similar things in the SARS-CoV-2 pandemic, just on an accelerated timeline. With the aid of clinical studies, we now have treatments such as , and . Physicians also know how to in ways that increase the chance of survival.

Vaccine development could end pandemic

This pandemic could end if the virus swept through the population killing millions but leaving the survivors with natural immunity. More likely the virus will snuff itself out when most of the population has been vaccinated with a SARS-CoV-2 vaccine. That is especially true in parts of the world where frequent testing and public health strategies are difficult to implement.

It took , with the first available in 1942. Other successes with and , and more recent ones like and , have provided blueprints for vaccine development.

Governments across the world have . This has led to multiple different companies developing their own different versions of vaccines. Normally, these take years to develop; however, by leveraging recent successes and accumulated knowledge, the . Normally, new vaccines go through phase 1 (safety), phase 2 (efficacy) and phase 3 (comparison) trials, but as , phases 2 and 3 can be combined for expediency. And large-scale manufacturing can begin when the vaccine is still in trials, potentially cutting years off the timeline.

Vaccine-445x297.jpg

Technology is at the forefront of the development of these vaccines. Some of the coronavirus , which essentially programs our cells to develop immune responses against SARS-CoV-2.

for SARS-CoV-2 proteins to which your body develops an immune response. Both types have thus far been shown to be effective, but long-term safety will remain controversial when vaccines are developed on such an expedited timeline.

Lessons learned

This disease, which began in Wuhan, Hubei Province, China, and was first is the perfect illustration of just how rapidly viruses spread in a connected world. We got previews of what could happen from the but the spread of SARS-CoV-2 has been on a different level. It has underscored that when we receive warnings about contagious viruses, rapid and decisive action must be taken in all parts of the world to reduce its spread.

Where there is , there have been profound reductions in virus transmission.

While the research that has made all this possible might fly under the radar right now, history will record this time as one of the greatest periods for scientific advancements.

The Conversation

This article is republished from under a Creative Commons license. Read the .

Enjoy reading 91亚色传媒 Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
David Pride
David Pride

David Pride is an associate director of microbiology, University of California San Diego

Get the latest from 91亚色传媒 Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Targeting toxins to treat whooping cough
Journal News

Targeting toxins to treat whooping cough

May 1, 2025

Scientists find that liver protein inhibits of pertussis toxin, offering a potential new treatment for bacterial respiratory disease. Read more about this recent study from the Journal of Biological Chemistry.

Elusive zebrafish enzyme in lipid secretion
Journal News

Elusive zebrafish enzyme in lipid secretion

May 1, 2025

Scientists discover that triacylglycerol synthesis enzyme drives lipoproteins secretion rather than lipid droplet storage. Read more about this recent study from the Journal of Biological Chemistry.

Scientists identify pan-cancer biomarkers
Journal News

Scientists identify pan-cancer biomarkers

April 30, 2025

Researchers analyze protein and RNA data across 13 cancer types to find similarities that could improve cancer staging, prognosis and treatment strategies. Read about this recent article published in Molecular & Cellular Proteomics.

New mass spectrometry tool accurately identifies bacteria
Journal News

New mass spectrometry tool accurately identifies bacteria

April 30, 2025

Scientists develop a software tool to categorize microbe species and antibiotic resistance markers to aid clinical and environmental research. Read about this recent article published in Molecular & Cellular Proteomics.

New tool matches microbial and metabolic metaproteomic data
Journal News

New tool matches microbial and metabolic metaproteomic data

April 30, 2025

Scientists develop a bioinformatics program that maps omics data to metabolic pathways. Read about this recent article published in Molecular & Cellular Proteomics

Meet Paul Shapiro
Interview

Meet Paul Shapiro

April 29, 2025

Learn how the JBC associate editor went from milking cows on a dairy farm to analyzing kinases in the lab.